Gambro's shares fall on disappointing year-end results
This article was originally published in Clinica
Executive Summary
Swedish dialysis company Gambro has conceded that its largest division, Gambro Healthcare, failed to meet its profitability expectations for last year. Shares in the company fell 5% to SEK66 on the release of its annual financial figures as total pre-tax profits fell short of analysts' predictions.